Company
TenSixty Bio
Expanding the druggable oncology universe.
Also known as TenSixty, TenSixty Biosciences, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, Massachusetts, United States
- Legal name
- TenSixty Biosciences, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
TenSixty studies tumor-selective epitopes that can be difficult to resolve with protein-level approaches—and translates those insights into oncology therapeutics.
Funding snapshot
- Total raised
- $7.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7.2M2022-08-15
Funding rounds
- Round, 2022
- $7.2M2022-08-15, SEC form D sold, 11 investors
Loading relationship preview